Table 2.
Conguillío | ||||||
---|---|---|---|---|---|---|
Treatment | Contamination (%)* | Survival (%)* | Oxidation (%)* | Shoots (%)* | Shoots number* | |
Control | NaClO at 4.9 mg mL−1 for 10 min. | 100 ± 0a | 100 ± 0a | 0 ± 0b | 0 ± 0a | 0 ± 0a |
T1 | Ca(ClO)2 at 50 mg mL−1 for 15 min. | 86.67 ± 11.55ab | 100 ± 0a | 0 ± 0b | 13.33 ± 11.55a | 0.60 ± 0.6a |
T2 | Ca(ClO)2 at 50 mg mL−1 for 20 min. | 93.33 ±11.55ab | 100 ± 0a | 0 ± 0b | 6.67 ± 11.55a | 0.27 ± 0.46a |
T3 | Ca(ClO)2 at 100 mg mL−1 for 15 min. | 80 ± 0b | 100 ± 0a | 0 ± 0b | 13.33 ± 11.55a | 0.67 ± 0.12a |
T4 | Ca(ClO)2 at 100 mg mL−1 for 20 min. | 100 ± 0a | 100 ± 0a | 0 ± 0b | 0 ± 0a | 0 ± 0a |
T5 | AgNO3 at 5 mg mL−1 for 5 min. | 80 ± 0b | 100 ± 0a | 100 ± 0a | 6.67 ± 11.55a | 0.07 ± 0.12a |
T6 | AgNO3 at 5 mg mL−1 for 10 min. | 86.67 ± 11.55ab | 100 ± 0a | 100 ± 0a | 6.67 ± 11.55a | 0.33 ± 0.42a |
T7 | AgNO3 at 10 mg mL−1 for 5 min. | 86.67 ± 11.55ab | 100 ± 0a | 100 ± 0a | 6.67 ± 11.55a | 0.27 ± 0.46a |
T8 | AgNO3 at 10 mg mL−1 for 10 min. | 80 ± 34.64ab | 100 ± 0a | 100 ± 0a | 20 ± 0a | 0.47 ± 0.50a |
T9 | AgNPs at 0.1 mg mL−1 for 60 min. | 100 ± 0a | 100 ± 0a | 0 ± 0b | 0 ± 0a | 0 ± 0a |
T10 | AgNPs at 0.1 mg mL−1 for 90 min. | 100 ± 0a | 100 ± 0a | 0 ± 0b | 0 ± 0a | 0 ± 0a |
T11 | AgNPs at 0.2 mg mL−1 for 60 min. | 100 ± 0a | 100 ± 0a | 0 ± 0b | 0 ± 0a | 0 ± 0a |
T12 | AgNPs at 0.2 mg mL−1 for 90 min. | 100 ± 0a | 100 ± 0a | 0 ± 0b | 0 ± 0a | 0 ± 0a |
Mean ± standard deviation. *Dunn’s Test. Equal letters did not differ statistically (p < 0.05).